161 related articles for article (PubMed ID: 21333046)
1. EDITORIAL COMMENT Re: Can we identify those patients who will benefit from prostate-sparing surgery? Predictive factors for invasive prostatic involvement by transitional cell carcinoma.
Djavan B
Can J Urol; 2011 Feb; 18(1):5536. PubMed ID: 21333046
[No Abstract] [Full Text] [Related]
2. Can we identify those patients who will benefit from prostate-sparing surgery? Predictive factors for invasive prostatic involvement by transitional cell carcinoma.
Arce J; Gaya JM; Huguet J; Rodriguez O; Palou J; Villavicencio H
Can J Urol; 2011 Feb; 18(1):5529-36. PubMed ID: 21333045
[TBL] [Abstract][Full Text] [Related]
3. Editorial comment.
Skinner EC
Urology; 2010 May; 75(5):1120; author reply 1120-1. PubMed ID: 20451729
[No Abstract] [Full Text] [Related]
4. Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion.
Esrig D; Freeman JA; Elmajian DA; Stein JP; Chen SC; Groshen S; Simoneau A; Skinner EC; Lieskovsky G; Boyd SD; Cote RJ; Skinner DG
J Urol; 1996 Sep; 156(3):1071-6. PubMed ID: 8709310
[TBL] [Abstract][Full Text] [Related]
5. Concomitant pathology in the prostate in cystoprostatectomy specimens: a prospective study and review.
Saad M; Abdel-Rahim M; Abol-Enein H; Ghoneim MA
BJU Int; 2008 Dec; 102(11):1544-50. PubMed ID: 18565169
[TBL] [Abstract][Full Text] [Related]
6. Developing selection criteria for prostate-sparing cystectomy: a review of cystoprostatectomy specimens.
Richards KA; Parks GE; Badlani GH; Kader AK; Hemal AK; Pettus JA
Urology; 2010 May; 75(5):1116-20. PubMed ID: 20080289
[TBL] [Abstract][Full Text] [Related]
7. Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients.
Stein JP; Clark P; Miranda G; Cai J; Groshen S; Skinner DG
J Urol; 2005 Apr; 173(4):1163-8. PubMed ID: 15758728
[TBL] [Abstract][Full Text] [Related]
8. Clinically significant prostate cancer found incidentally in radical prostatectomy specimens.
Blick C; Jones A; Fawcett DP
BJU Int; 2007 May; 99(5):1170. PubMed ID: 17437450
[No Abstract] [Full Text] [Related]
9. Depth and origin of prostatic involvement by urothelial carcinoma: prognostic significance and staging interpretation.
Kiyoshima K; Kuroiwa K; Uchino H; Yokomizo A; Naito S
Jpn J Clin Oncol; 2011 May; 41(5):642-6. PubMed ID: 21310731
[TBL] [Abstract][Full Text] [Related]
10. Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance.
Shen SS; Lerner SP; Muezzinoglu B; Truong LD; Amiel G; Wheeler TM
Hum Pathol; 2006 Jun; 37(6):726-34. PubMed ID: 16733214
[TBL] [Abstract][Full Text] [Related]
11. Editorial comment on: Prognostic implications of lymphangiogenesis in muscle-invasive transitional cell carcinoma of the bladder.
Lotan Y
Eur Urol; 2008 Mar; 53(3):579-80. PubMed ID: 17804152
[No Abstract] [Full Text] [Related]
12. Commentary on prostate and urothelial carcinoma in cystoprostatectomy specimens.
Lotan Y
J Urol; 2008 May; 179(5 Suppl):S33-4. PubMed ID: 18405746
[No Abstract] [Full Text] [Related]
13. [Prostatic urothelial location of a tumor of the bladder].
Coulange C; Lechevallier E; de Fromont M
Prog Urol; 1997 Feb; 7(1):128-31. PubMed ID: 9116731
[TBL] [Abstract][Full Text] [Related]
14. The frequency of prostatic involvement in radical cystectomy specimens for transitional cell carcinoma of the bladder.
Basiri A; Ozhand A; Karami H; Parham HA; Safarinejad MR
J Pak Med Assoc; 2008 Sep; 58(9):479-81. PubMed ID: 18846793
[TBL] [Abstract][Full Text] [Related]
15. Editorial comment.
Benson MC
J Urol; 2010 Jun; 183(6):2170. PubMed ID: 20399469
[No Abstract] [Full Text] [Related]
16. Prostatic capsule- and seminal-sparing cystectomy for bladder carcinoma: initial results for selected patients.
Botto H; Sebe P; Molinie V; Herve JM; Yonneau L; Lebret T
BJU Int; 2004 Nov; 94(7):1021-5. PubMed ID: 15541120
[TBL] [Abstract][Full Text] [Related]
17. Invasive T1 bladder cancer: indications and rationale for radical cystectomy.
Stein JP; Penson DF
BJU Int; 2008 Aug; 102(3):270-5. PubMed ID: 18494831
[TBL] [Abstract][Full Text] [Related]
18. Urothelial carcinoma in the prostatic urethra and prostate: current controversies.
Liedberg F; Chebil G; Månsson W
Expert Rev Anticancer Ther; 2007 Mar; 7(3):383-90. PubMed ID: 17338657
[TBL] [Abstract][Full Text] [Related]
19. Prediction of prostatic involvement by urothelial carcinoma in radical cystoprostatectomy for bladder cancer.
Mazzucchelli R; Barbisan F; Santinelli A; Scarpelli M; Galosi AB; Lopez-Beltran A; Cheng L; Kirkali Z; Montironi R
Urology; 2009 Aug; 74(2):385-90. PubMed ID: 19501882
[TBL] [Abstract][Full Text] [Related]
20. The risk factor for urethral recurrence after radical cystectomy in patients with transitional cell carcinoma of the bladder.
Cho KS; Seo JW; Park SJ; Lee YH; Choi YD; Cho NH; Yang SC; Hong SJ
Urol Int; 2009; 82(3):306-11. PubMed ID: 19440019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
